CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Industry Giants Say Covid-19 Offers A 'Significant Opportunity' To Fast-Track Cancer Eradication

Industry Giants Say Covid-19 Offers A...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

What You Should Know About Biotechnology

What You Should Know About...

How Advanced Technologies Improves Clinical Trials

How Advanced Technologies Improves...

Why Create Patient Recruitment Strategies for Clinical Trials

Why Create Patient Recruitment...

Clinical Trials: Top Ways to Make Patient Recruitment Process More Efficient

Clinical Trials: Top Ways to Make...

Patient Recruitment: Some Excellent Strategies to Keep in Mind

Patient Recruitment: Some Excellent...

Industry Giants Say Covid-19 Offers A 'Significant Opportunity' To Fast-Track Cancer Eradication

Industry Giants Say Covid-19 Offers A...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

What You Should Know About Biotechnology

What You Should Know About...

How Advanced Technologies Improves Clinical Trials

How Advanced Technologies Improves...

Why Create Patient Recruitment Strategies for Clinical Trials

Why Create Patient Recruitment...

Clinical Trials: Top Ways to Make Patient Recruitment Process More Efficient

Clinical Trials: Top Ways to Make...

Patient Recruitment: Some Excellent Strategies to Keep in Mind

Patient Recruitment: Some Excellent...

Major Factors Revamping Asian Biopharma Supply Chain

Life Sciences Review | Tuesday, August 24, 2021
Tweet

The landscape is changing rapidly for Asia’s biopharma sector, which has been thrust to the center of the battle against COVID-19.


FREMONT, CA: Most pharma have complex supply chains under-utilized, inefficient and ill-armed to cope with the sort of products coming down the pipeline. A new report predicts that to meet the demands of a fast-evolving marketplace and the transformation from patient to outcome, the pharma supply chain will require a radical overhaul. Several forces are reshaping the environment in which the sector operates and dictating the need for a different supply chain. Here are some major trends that are shaping the Asian biopharma supply chain. 



  • Making Medicines Faster and Cheaper 


Making medicines faster and cheaper is a new normal. But against the debate on quality and cost, the broader innovation is only accelerating. As big global firms ramp up output, the requirement for technology that boosts productivity should grow. Smaller companies are stepping up to take bigger roles. The objective to bring new products to market faster is reflected across Asia. There is major investment across all sub-sectors of healthcare start-ups, comprising med-tech and biopharma, where players are expected in fields like the cell, gene therapies and small molecules.



  • Environmental-Friendly Packaging


Consumers are now expecting products manufactured and delivered through sustainable processes from sustainable firms. And while pharma packaging presents waste issues, more sustainable solutions are on the rise, especially in the most challenging temperature range to sustain. Similarly, active temperature-controlled speciality containers, which avoid the need for gel packs or dry ice, will remain in demand – especially for transporting temperature-sensitive active pharmaceutical ingredients.



  • Better Manufacturing Agility


As the race to discover, develop and market medicine increases, examples of differentiated, value-specific supply chains for various product types appear everywhere. The COVID-19 pandemic highlighted the need for agility. Fears over severe shortages of antibiotics and medicines have increased. With the prolonged closure of China’s factories, the vulnerability of the pharma supply chain became evident. The pharma supply chain, including biopharma, will need the flexibility to manage its supply chain.


See Also :- Top Tech Solutions for Healthcare


Weekly Brief

loading
Top 10 Biotech Startups in APAC - 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/major-factors-revamping-asian-biopharma-supply-chain-nwid-301.html